Pictet Asset Management
BSX icon

Pictet Asset Management’s Boston Scientific BSX Stock Holding History

Pictet Asset Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$102M Sell
2,393,080
-2,726,977
-53% -$148M 0.1% 224
2026
Q1 		$321M Buy
5,120,057
+820,284
+19% +$65.6M 0.34% 69
2025
Q4 		$410M Buy
4,299,773
+209,413
+5% +$20.5M 0.4% 51
2025
Q3 		$399M Sell
4,090,360
-303,099
-7% -$31.4M 0.38% 62
2025
Q2 		$472M Sell
4,393,459
-70,913
-2% -$7.18M 0.48% 49
2025
Q1 		$450M Buy
4,464,372
+847,477
+23% +$85.3M 0.5% 45
2024
Q4 		$323M Buy
3,616,895
+691,267
+24% +$60.9M 0.35% 74
2024
Q3 		$245M Sell
2,925,628
-219,305
-7% -$17.3M 0.27% 96
2024
Q2 		$242M Sell
3,144,933
-204,360
-6% -$15M 0.28% 94
2024
Q1 		$229M Sell
3,349,293
-376,672
-10% -$24.2M 0.25% 102
2023
Q4 		$215M Buy
3,725,965
+117,025
+3% +$6.25M 0.24% 116
2023
Q3 		$191M Buy
+3,608,940
New +$189M 0.24% 123

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Pictet Asset Management's BSX Position: Q2 2026 in Review

Pictet Asset Management reduced its Boston Scientific (BSX) stake by 53% in Q2 2026, selling an estimated $148M and leaving 2,393,080 shares worth $102M. The position accounts for 0.1% of the portfolio, ranked #224.

Pictet Asset Management first reported a position in BSX in Q3 2023 and has held it in 12 quarters since. The position peaked at $472M in Q2 2025. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Pictet Asset Management held 2,393,080 shares of Boston Scientific worth $102M as of Q2 2026.
  • Pictet Asset Management sold 2,726,977 Boston Scientific shares in Q2 2026, an estimated $148M.
  • Boston Scientific made up 0.1% of Pictet Asset Management's portfolio in Q2 2026, its #224 holding.
  • Pictet Asset Management first reported a position in Boston Scientific in Q3 2023 and has held it in 12 quarters since.
  • Pictet Asset Management's Boston Scientific position peaked at $472M in Q2 2025.
  • 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.